Gout, heart health, and diabetes
Prepared 2026-10-29 · Read as Markdown
Gout often sits alongside conditions such as high blood pressure, diabetes, kidney disease, and cardiovascular disease. That makes a broader health review useful. It does not prove that gout caused someone’s heart condition or that reaching a urate target alone will prevent a heart attack or treat diabetes. [S06]

Your heart history affects medicine choices
Cardiovascular disease and blood-pressure control can influence flare treatment. Febuxostat has a US boxed warning about cardiovascular death; NICE favors allopurinol with major cardiovascular disease. Ask the prescriber to explain how your actual history affects the options. S03 S11
Keep important existing treatments in view
Some diuretics affect urate, but the condition they treat still matters. ACR conditionally supports switching hydrochlorothiazide and choosing losartan when feasible, while advising against stopping indicated low-dose aspirin. Do not stop heart treatment because it appears on a gout-risk list. S02
Make diabetes part of the flare discussion
The plan should account for diabetes, particularly when a corticosteroid is being considered. Medicine choice and monitoring need to be individualized rather than taken from a universal rescue regimen. S03
Reconcile food and fluid advice
A sustainable eating pattern, appropriate activity, and weight management can support overall care. Hydration instructions must respect heart-failure or kidney-related fluid restrictions. A purine number cannot replace attention to sugar, alcohol, and other nutritional needs. S02 S08 S15
Questions for the next review
What are the main priorities for my heart and metabolic health? Do my gout medicines interact with existing treatment? Which changes in kidney function, blood pressure, or diabetes control should prompt a plan review? Ask for answers that cover the whole regimen.
Related pages
- Febuxostat
- Medicine interactions and safety
- Food and drink with gout
- Gout, kidney disease and kidney stones
Sources
- S02: 2020 American College of Rheumatology Guideline for the Management of Gout
- S03: NICE NG219: Gout, diagnosis and management, recommendations
- S06: NIAMS: Gout overview, symptoms, causes and risk factors
- S08: NHS: Gout
- S11: DailyMed: ULORIC febuxostat prescribing information
- S15: NICE Evidence Review I: Diet and lifestyle modifications for gout